Lysosomes, pivotal in tumor progression and therapy resistance, sustain cancer survival through drug tolerance and stress adaptation. Conventional lysosome-disrupting approaches faced transient efficacy from poor targeting or cellular repair mechanisms. To address this, we engineered a biomimetic nanoplatform (FeCO@MP-...
Shuai-Peng Feng, Lu-Ping Sha, Zi-Wei Yan et al.· International journal of pha...· 0 citations
Chemotherapy resistance and immunosuppression are the current key bottlenecks in tumor treatment. In the tumor microenvironment (TME), cancer‐associated fibroblasts (CAFs) secrete dense extracellular matrix and various immunosuppressive factors, forming a dynamic “tumor–CAFs crosstalk”, which drives the progression o...
Overall, DCMP provides a multimodal imaging-guided nanotherapeutic strategy that combines chemical tumor killing with physical tumor matrix modulation to enhance chemo-chemodynamic-photothermal antitumor therapy.
Long Wan, Lu Zou, Dong-Lin Bian et al.· Colloids and Surfaces B: Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.